Therapeutic vaccines for prostate cancer: recent advances and future directions

Expert Review of Vaccines
Julius Strauss, Ravi A Madan

Abstract

In recent years, therapeutic cancer vaccines have emerged as a viable and promising treatment for prostate cancer. Beyond sipuleucel-T, phase III trials are evaluating multiple vaccine platforms in men with this disease. Growing data evaluating vaccine therapies suggests that these agents are more effective in patients with more indolent and possibly also earlier stages of disease. In addition, a wealth of preclinical data has shown that traditional prostate cancer treatments including anti androgens, cytotoxic and radiation therapies may provide immunologic synergy when given in combination with vaccine platforms. Building off this data, numerous clinical trials are evaluating therapeutic cancer vaccines in early stage prostate cancer and also in combination with traditional prostate cancer therapies. In addition, in order to optimize immune responses, ongoing trials are evaluating vaccines in combination with immune checkpoint inhibitors. Preliminary data from these trials have been promising and are offering an exciting glimpse at the future of immunotherapy for this disease.

References

May 26, 1999·Human Gene Therapy·J R HermanP T Scardino
Dec 6, 2001·Proceedings of the National Academy of Sciences of the United States of America·M MercaderE D Kwon
Jun 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mala ChakrabortyJames W Hodge
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard L KaufmanLouis M Weiner
May 4, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James L GulleyWilliam Dahut
Aug 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tracy S P HengRichard L Boyd
Feb 14, 2006·International Journal of Radiation Oncology, Biology, Physics·Tetsuo FujitaTimothy C Thompson
Feb 21, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Philip M ArlenWilliam Dahut
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric J SmallRobert M Hershberg
Jun 16, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Jeanny B Aragon-ChingJames L Gulley
Aug 21, 2007·The Journal of Urology·Philip M ArlenJames L Gulley
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James H FinkeRonald Bukowski
Mar 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer S KoJames H Finke
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip W KantoffWayne R Godfrey
Apr 21, 2010·Seminars in Immunology·Yuting MaLaurence Zitvogel
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Sep 8, 2010·The New England Journal of Medicine·Philip W KantoffUNKNOWN IMPACT Study Investigators
May 25, 2012·The New England Journal of Medicine·Susan M HinikerSusan J Knox
Jun 5, 2012·The New England Journal of Medicine·Antoni Ribas
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Feb 1, 2013·International Journal of Cancer. Journal International Du Cancer·James W HodgeSofia R Gameiro
Apr 10, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emmanuel S Antonarakis, Mario A Eisenberger
Jul 10, 2013·Cancer Immunology, Immunotherapy : CII·James L GulleyPeter A Pinto
Jul 19, 2013·The New England Journal of Medicine·C ParkerUNKNOWN ALSYMPCA Investigators
Sep 21, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mario Sznol, Lieping Chen
Sep 21, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andressa ArdianiJames W Hodge
Jan 30, 2014·International Journal of Cancer. Journal International Du Cancer·Benedetto FarsaciJeffrey Schlom
Mar 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Geraldine O'Sullivan CoyneJames L Gulley
Sep 19, 2014·World Journal of Gastrointestinal Oncology·María Del Carmen Gómez-MateoAntonio Ferrández-Izquierdo
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Dec 8, 2014·Seminars in Radiation Oncology·Charlie Garnett-BensonSofia R Gameiro
Jan 7, 2015·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Dec 15, 2017·Chinese Medical Journal·De-Xin Dong, Zhi-Gang Ji
Feb 29, 2020·Journal of Cellular and Molecular Medicine·Peng AnFudi Wang
Oct 22, 2016·Oncotarget·Erika HeningerJoshua M Lang
Jun 24, 2017·Current Opinion in Supportive and Palliative Care·Ravi A Madan, James L Gulley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.